Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation
Publication Type:
Journal Article
Authors:
Picciotto, F.P.;
Tritto, G.;
Lanza, A.G.;
Addario, L.;
De, Luca M.;
Di Costanzo, G.G.;
Lampasi, F.;
Tartaglione, M.T.;
Marsilia, G.M.;
Calise, F.;
Cuomo, O.;
Ascione, A.Source:
J Hepatol, Volume 46, Issue 3, p.459-465 (2007)
Keywords:
Adult,
adverse effects,
Aged,
analysis,
Antiviral Agents,
clinical trial,
Cohort Studies,
Disease Progression,
Dose-Response Relationship,Drug,
drug effects,
drug therapy,
Female,
Genotype,
HCV,
Hepacivirus,
Hepatitis C,
Humans,
Infection,
Intention to Treat Analysis,
interferon,
Interferon Alfa-2a,
Interferon-alpha,
Italy,
Liver,
Liver Transplantation,
Male,
methods,
Middle Aged,
Mortality,
nonresponder,
Patients,
peginterferon,
pegylated interferon,
physiology,
Polyethylene Glycols,
prevention & control,
Prognosis,
Prospective Studies,
Proteins,
Recombinant Proteins,
Recurrence,
Ribavirin,
Survival,
Survival Rate,
therapeutic use,
therapy,
transplantation,
treatment,
Treatment Failure,
Treatment Outcome
